Biocon Biologics to acquire Viatris’ biosimilars business for $3.35B
Biocon Biologics Ltd (BBL), a Biocon subsidiary, announced the acquisition of Viatris' biosimilars business for $3.3 ...
Read moreBiocon Biologics Ltd (BBL), a Biocon subsidiary, announced the acquisition of Viatris' biosimilars business for $3.3 ...
Read moreBengaluru, Nov 3 (PTI): Biocon Ltd today said it has earned the distinction of being the ...
Read moreTech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]